Ranbaxy loses Lipitor patent case in Denmark

Pfizer has won a patent challenge in Denmark by Indias largest drug-maker Ranbaxy Laboratories on atorvastatin, the active ingredient of the worlds largest selling cholesterol drug,

Denmark Court rules in Pfizer’s favour over Lipitor case

Ranbaxy settles patent disputes with Pfizer

Pfizer ready to settle Apotex suit

Novartis to divert India investment after patent case

SC appoints new technical member for Glivec case

Pfizer agrees to settle Lipitor-related suit

Editorial: Survival strategy for generics

Cipla, Roche patent battle to resume at Delhi HC

This entry was posted on Saturday, August 30th, 2008 at 5:10 pm and is filed under Business Standard. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.

Indian Stock Market

Ranbaxy loses Lipitor patent case in Denmark

Leave a Reply

Categories

Archives

Feed

Links

Subscribe by E-Mail :

Recent Posts

Recent Comments

Indian Stock Market News